RonanRx Inc. YC 지원서

Summer 2026Active

San Francisco

RonanRx Inc.은(는) Summer 2026 배치에서 Healthcare 회사로 Y Combinator를 거쳤습니다. 아래에는 회사의 사업 내용, 창립자, 그리고 실제 YC 양식에 맞춰 재구성한 YC 지원서가 있습니다.

YC 배치: Summer 2026
산업: Healthcare
위치: San Francisco
팀 규모: 5
상태: Active
출시됨: 2026

창업자

Lloyd ArmbrustFounder/CEO
Emily ColmanFounder

RonanRx Inc.의 사업 내용

RonanRX is a full-stack pharmaceutical company, starting with personalized peptides and GLP-1s. In our first 10 weeks, we went from having no pharmacy to being licensed in 33 states. Since launch, we’ve grown 50% week over week. We manufacture the medications ourselves, sell directly to patients, and eliminate the layers of middlemen that make prescription drugs more expensive. What makes this possible is AI. Traditional pharmaceutical companies are built to manufacture one drug for millions of people. RonanRX is purpose-built to personalize treatment for each patient: different biology, different response, different dose. Patients come directly to RonanRX or through doctors using our platform. Every patient completes our medical intake, meets with a licensed doctor through our telehealth platform, and receives a personalized prescription when appropriate. From there, we manufacture the medication ourselves and deliver it directly to the patient. Labs, wearables, medical history, treatment response, and other health data feed back into the platform so doctors can continuously refine treatment over time. Before AI, doing this for every patient at scale was impossible. We didn't invent the demand we are seeing. 80 Million people are on a GLP-1 and millions more are using Peptides. We're building a better way to manufacture, personalize, prescribe, and deliver them. Our founders have built and exited multiple companies, raised more than $100M, built a $50M U.S. medical manufacturing business, and spent years developing peptide therapeutics at companies including Eli Lilly and AbbVie. We’re just getting started with peptides and GLP-1s. Next comes hormone therapy and the rest of personalized medicine.

RonanRx Inc.의 YC 지원서, 재구성됨

Y Combinator 지원

RonanRx Inc., Summer 2026 기수. 공개 데이터를 기반으로 작성된 실제 지원 질문.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

RonanRx Inc.

Describe what your company does in 50 characters or less.

Personalized peptides & GLP-1s, direct to patient.

What is your company going to make? Please describe your product and what it does or will do.

We are building RonanRX, a pharmaceutical company focused on personalized peptides and GLP-1 medications. Patients complete an online medical intake, meet with a licensed doctor through our telehealth platform, and receive a tailored prescription. We manufacture the drugs ourselves and ship directly to the patient, taking care of every step from medical consultation to delivery. We use AI to make it possible to personalize treatments at scale and close the feedback loop between patient data and ongoing care.

Where do you live now, and where would the company be based after YC?

We are based in San Francisco, CA and will continue to be based there after YC.

Explain your decision regarding location.

San Francisco is our home and it's where our team, facility, and network are already set up. It's also the best place for health tech and for building a telehealth company quickly.

전체 지원서에서 21개의 추가 답변

Founders, Progress, Idea, Equity, Curious, Batch Preference는 전체 버전에 있습니다. 무료 계정을 만들어 YC Insights에서 모든 YC 배치 옆에 열어보세요.

전체 지원 보기

자주 묻는 질문

RonanRx Inc.의 실제 YC 지원서인가요?

아닙니다. Y Combinator는 제출된 지원서를 비공개로 유지합니다. 이것은 재구성된 것입니다. 실제 YC 양식 질문에 RonanRx Inc.의 공개 데이터(출시 노트, 창업자 배경, 제품 설명)를 기반으로 답변했습니다. RonanRx Inc.과 같은 회사가 YC에 어떻게 자신을 소개하는지 보여주며, 그들이 제출한 텍스트는 아닙니다.